placeholder image
L. C. Liu All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas. 
    Neurooncol Adv. 2023
  • Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies. 
    British Journal of Cancer. 2023
  • Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy. 
    Breast Cancer Research and Treatment. 2020
  • Phase Ib/II clinical trial of pembrolizumab with bevacizumab for metastatic renal cell carcinoma: BTCRC-GU14-003. 
    Journal of Clinical Oncology. 2020
  • Phase I study of IGF-methotrexate conjugate in the treatment of advanced tumors expressing IGF-1R. 
    American Journal of Clinical Oncology. 2019
  • Phase I study of aurora A kinase inhibitor alisertib (MLN8237) in combination with selective VEGFR inhibitor pazopanib for therapy of advanced solid tumors. 
    American Journal of Clinical Oncology. 2019
    • Contact
    full name
  • L. C. Liu
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration